statements

Syschem (India) Ltd.

BSE: 531173

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

31.50-0.9 (-2.78%)

23 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Syschem (India) Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	68.49	59.00	113.56	198.66	331.68	573.77	573.66
Cost of Operating Revenue	63.21	48.67	96.28	178.44	310.17	527.13	523.19
Gross Profit	5.28	10.33	17.27	20.22	21.51	46.64	50.47
Gross Margin	7.7	17.5	15.2	10.2	6.5	8.1	8.8
Total Operating Expenses	75.73	61.02	107.61	194.46	330.64	556.74	559.35
Operating Profit	-7.24	-2.02	5.94	4.20	1.04	17.03	14.31
Operating Margin	-10.6	-3.4	5.2	2.1	0.3	3.0	2.5
Financing Income/(Expense) - Net	-0.03	-0.21	0.01	-0.14	-0.05	-2.24	-2.71
Profit before Taxes	-7.31	-2.17	6.15	4.11	1.01	14.79	11.66
Income Taxes	-1.75	-0.47	1.64	1.35	0.55	3.86	4.07
Profit after Tax	-5.57	-1.71	4.51	2.76	0.46	10.93	7.59
PAT Margin	-8.1	-2.9	4.0	1.4	0.1	1.9	1.3
EPS - Basic - ex Extraordinary Items	-2.48	-0.70	1.30	0.78	0.11	2.53	1.85
EPS - Diluted - ex Extraordinary Items	-2.48	-0.70	1.41	0.78	0.11	1.93	1.85
EBIT	-7.24	-2.02	5.94	4.20	1.04	17.03	14.31
EBITDA	-4.88	0.57	8.65	6.98	3.98	21.09	19.17
EBITDA Margin	-7.1	1.0	7.6	3.5	1.2	3.7	3.3

Balance Sheet

Abridged

Understanding Balance Sheet

Syschem (India) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	32.52	42.14	23.55	58.57	126.35	161.43	218.57
Long-Term Investments	-	-	-	-	-	-	-
Property Plant & Equipment - Net	-	30.55	31.48	30.80	34.67	53.40	67.60
Total Non-Current Assets	1.94	35.03	36.26	34.15	37.68	55.83	73.18
Total Assets	62.45	77.17	59.81	92.71	164.03	217.26	291.74
Total Current Liabilities	52.44	40.89	25.54	42.98	96.77	124.05	163.03
Long Term Debt	-	12.56	1.75	1.61	0.45	-	0.33
Total Non-Current Liabilities	-	29.15	27.33	27.43	10.30	1.92	6.29
Total Liabilities	52.44	70.05	52.87	70.41	107.07	125.97	169.32
Total Shareholders' Equity	10.01	7.12	6.94	22.30	56.96	91.29	122.43
Total Equity	10.01	7.12	6.94	22.30	56.96	91.29	122.43
Total Liabilities & Equity	62.45	77.17	59.81	92.71	164.03	217.26	291.74

Cash Flow

Abridged

Understanding Cash Flow Statement

Syschem (India) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.32	-2.93	0.87	7.34	5.56	3.42	14.99
Working Capital - Increase/(Decrease)	3.12	6.62	-0.01	-15.82	-31.35	-13.56	-9.64
Net CF from Operating Activities	3.44	3.69	0.86	-8.49	-25.79	-10.14	5.35
Capital Expenditures - Net	3.44	5.11	3.43	1.96	6.67	21.69	18.26
Net CF from Investing Activities	-3.62	-3.80	-0.86	-1.70	-6.58	-21.69	-19.59
Dividends Paid - Cash - Total	-	-	-	-	-	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	10.73	31.89	33.87	20.21
Net Cash Flow from Financing Activities	-	-	-	10.73	31.89	33.87	20.21
Free Cash Flow to Equity	0.00	-1.42	-2.57	-10.45	-32.45	-31.83	-12.91
Free Operating CF net dividend	0.00	-1.42	-3.55	-10.45	-32.47	-31.86	-12.91
Free Operating CF	0.00	-1.42	-3.55	-10.45	-32.47	-31.86	-12.91

Business Segment Analysis

FY End:

Mar 26

Syschem (India) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceutical (100.0%)₹ 18.26 Cr

Revenue / Sales

Pharmaceutical (100.0%)₹ 573.77 Cr

Assets

Pharmaceutical (100.0%)₹ 291.74 Cr

Operating Income

Pharmaceutical (100.0%)₹ 17.03 Cr

Regional Segment Analysis

Syschem (India) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Syschem (India) Ltd.

Historical Segment Analysis

Track how Syschem (India) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Pharmaceutical	2	7	22	18

Frequently Asked Questions

What is the revenue of Syschem (India) Ltd.?

The latest trailing twelve month revenue of Syschem (India) Ltd. is ₹ 573.66 Cr, reflecting a 1-year growth of 62.30% and a 3-year CAGR of 59.43%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Syschem (India) Ltd.?

The latest trailing twelve month net profit (PAT) of Syschem (India) Ltd. is ₹ 6.14 Cr, with a 3-year earnings CAGR of -5.51%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Syschem (India) Ltd.?

The trailing twelve month EBITDA of Syschem (India) Ltd. is approximately ₹ 17.03 Cr (based on an operating margin of 2.97%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Syschem (India) Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Syschem (India) Ltd. is 1.40. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Syschem (India) Ltd.?

The debt-to-equity ratio of Syschem (India) Ltd. stands at 0.00. The interest coverage ratio is 5.27x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Syschem (India) Ltd.?

The estimated book value per share of Syschem (India) Ltd. is 22.83 (derived from a P/B ratio of 1.38 and market price of ₹ 31.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Syschem (India) Ltd.?

The trailing twelve month operating cash flow of Syschem (India) Ltd. is ₹ 5.35 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Syschem (India) Ltd. report consolidated or standalone financials?

Syschem (India) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.